USA flag logo/image

An Official Website of the United States Government

BIOSYNTHESIS OF A NEW ANTICHOLESTEROLGENIC COMPOUND

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
8072
Program Year/Program:
1988 / SBIR
Agency Tracking Number:
8072
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Somatogenetics International
350 Interlocken Pkwy #100 Broomfield, CO 80020
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1988
Title: BIOSYNTHESIS OF A NEW ANTICHOLESTEROLGENIC COMPOUND
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE LONG TERM OBJECTIVE OF THIS PROPOSAL IS TO DEVISE A METHOD FOR THE LARGE SCALE BIOSYNTHESIS OF A NEGATIVE REGULATOR OF MAMMALIAN CHOLESTEROL BIOSYNTHESIS. THIS COMPOUND HAS POTENTIAL USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA AND MAY REDUCE THE OCCURRENCE OF ATHEROSCLEROTIC HEART DISEASE. AS A STEP TOWARD ACHIEVING THE BIOSYNTHESIS OF THIS COMPOUND, WE PROPOSE TO ISOLATE THEGENE ENCODING A KEY ENZYME REQUIRED FOR THE SYNTHESIS OF THIS REGULATORY MOLECULE, DETERMINE THE COMPLETE NUCLEOTIDE SEQUENCE OF THE GENE AND THE LOCATION OF TRANSCRIPTIONAL INITIATION. THE GENE WILL BE CLONED FROM THE YEAST SACCHAROMYCES CEREVISIAE BY COMPLEMENTATION OF AN AUXOTROPHIC MUTATION IN THAT GENE OR BY OVERCOMING THE EFFECTS OF A SPECIFIC ENZYMATIC INHIBITOR THROUGH GENE DOSAGE. THE CLONE, AND THE INFORMATION PROVIDED BY ITS SEQUENCE, WILL BE USED TO CONSTRUCT A MICROBIAL STRAIN CAPABLE OF PRODUCING THE REGULATORY MOLECULE. SUCH A STRAINMAY ALLOW COMMERCIAL SCALE PRODUCTION OF THE COMPOUND FOR FURTHER TESTING AND DEVELOPMENT.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

Somatogenetics International
350 Interlocken Pky #100 Broomfield, CO 80020

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No